Headquartered in the UK, GlaxoSmithKline (GSK) is one of the world's leading research-based pharmaceutical and healthcare companies dedicated to improving the quality of human life by enabling people to do more, feel better and live longer.

In Singapore, GSK brings innovative medicines to patients to fight diseases and treat illnesses, as well as vaccines to help prevent diseases. Apart from providing innovative medicines, GSK is also committed to biomedical research. A new Centre for Research in Cognitive and Neurodegenerative Disorders was built in the vibrant Biopolis in Singapore. Singapore also serves as a major hub for the Biologicals R&D Centre that is responsible for clinical trials for Australasia/Asia Pacific.  Over-the-counter (OTC) medicines, oral healthcare and nutritional healthcare products are also provided for millions of people in Asia by GSK Consumer Healthcare.

Singapore stands as a key strategic location of GSK's global manufacturing and supply sites for its wide range of active pharmaceutical compounds. Furthermore, Singapore is also the site for GSK's first primary vaccine manufacturing plant in Asia.  To date, GSK's total investment in Singapore exceeds S$1 billion.